Vence Bonham on diversity and impact in ...

Hugo Aerts and Ray Mak from Mass General Brigham join Lucy Dunbar to discuss FaceAge, a deep learning tool that estimates biological age from simple face photographs, and its implications in aiding clinicians in predicting prognoses for people with cancer.Read the full article:ht ... Show More

Mohamed Omar joins The Lancet Digital Health to discuss pathology and generative AI from a Digital Health Perspective. We explore expert journeys, AI applications in diagnostics, GPT-4's role, integration challenges, ethical considerations, democratisation of knowledge, and futur ... Show More

Developing and validating an algorithm for automated circulatory arrest detection with wrist-derived photoplethysmography with Judith Bonnes from the Department of Cardiology of the Radboud University Medical Center - Netherlands.Read the full article:https://www.thelancet.com/jo ... Show More

<p>Can a multi-metabolite blood test improve early pancreatic cancer detection? We spoke to Julia Mayerle about the METAPAC study, which sought to validate the ability of plasma metabolic signatures to find resectable tumors and reduce unnecessary invasive procedures in high-risk ... Show More

Breast cancer is the most common cancer among women globally. And yet, many people pass up opportunities to get screened for the disease, often because of the invasive and sometimes painful process of mammograms. Chemist and professor Simona Francese presents a potentially ground ... Show More

<p>In this episode of OncoTalks, Dr. Paul Conkling and Dr. Kashif Ali explore how minimal residual disease (MRD) testing using circulating tumor DNA (ctDNA) is reshaping breast cancer management. They discuss how this innovative approach enables the detection of molecular disease ... Show More

<p class="" style="white-space:pre-wrap;">Not to be confused with “carcinoma of unknown primary,” in this episode of metastatic disease of “origin TBD”, we discuss the workup of a mass noted incidentally on imaging. This is a very high yield topic often faced on solid oncology co ... Show More

<p>Ninja Nerds!</p><p><br/>In this episode of the Ninja Nerd Podcast, Zach and Rob discuss two high-yield, board-relevant cases highlighting the diagnosis, staging, and treatment of esophageal adenocarcinoma and intestinal-type gastric adenocarcinoma.<br/><br/>We begin with a 56- ... Show More

In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More

<p>Breast cancer is the most common cancer among women globally. And yet, many people pass up opportunities to get screened for the disease, often because of the invasive and sometimes painful process of mammograms. Chemist and professor Simona Francese presents a potentially gro ... Show More

<p>Ninja Nerds!</p><p>In this episode of the Ninja Nerd Podcast, Zach and Rob discuss <b>Colorectal Cancer</b>. This comprehensive discussion focuses on the clinical presentation, pathogenesis, and management of one of the most common malignancies encountered in clinical practice ... Show More

Joël Guigay discusses the ELAN-FIT and ELAN-UNFIT trials in older people with head and neck cancer, published in The Lancet Healthy Longevity, and the importance of geriatric assessments in clinical trials of older cancer patients.Read the full articles:https://www.thelancet.com/ ... Show More